Related Experiment Videos
Animal models in xenotransplantation.
1London Health Sciences Center, University Campus, 339 Windermere Road, London, Ontario, N6A 5A5, Canada. zzhong@julian.uwo.ca
Expert Opinion on Investigational Drugs
|November 4, 2000
Summary
Xenotransplantation research uses animal models to overcome immunological barriers. Small animal models offer molecular insights, while large animal models, like pig-to-primate, show promise for clinical xenotransplantation success.
Area of Science:
- Transplantation immunology
- Medical research
- Animal models in research
Background:
- Severe donor organ shortage drives xenotransplantation research.
- Xenotransplantation offers patient benefits and business opportunities.
- Immunological barriers, physiological incompatibility, zoonosis, and ethics are key challenges.
Purpose of the Study:
- To review animal models for overcoming xenotransplantation immunological barriers.
- To highlight the utility of small and large animal models.
- To discuss progress in addressing hyperacute and acute vascular rejection.
Main Methods:
- Review of small animal models (rodents) for studying rejection mechanisms.
- Analysis of specific models for hyperacute rejection (HAR): guinea-pig-to-rat, mouse-to-rabbit, etc.
- Examination of large animal models (pig-to-primate) for clinical relevance and chronic rejection studies.
Main Results:
- Small animal models, particularly mice, allow molecular dissection of rejection.
- Hyperacute rejection (HAR) can be overcome using transgenic pig-to-primate models.
- Acute vascular rejection remains a significant barrier; novel models are being developed.
Conclusions:
- Animal models are crucial for advancing xenotransplantation.
- Continued research with diverse models is essential for clinical success.
- Overcoming immunological barriers is key to realizing xenotransplantation's potential.